Restasis and Anastrozole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Restasis (cyclosporine) and Anastrozole (anastrozole). Common drug interactions include fatigue among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Restasis and Anastrozole. It is created by eHealthMe based on reports of 65 people who take the same drugs from the FDA, and is updated regularly.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

What is Anastrozole?

Anastrozole has active ingredients of anastrozole. It is often used in breast cancer. eHealthMe is studying from 21,892 Anastrozole users. Check the latest studies of Anastrozole.

On Jul, 16, 2026

65 people who take Restasis and Anastrozole together, and have interactions are studied.

Restasis and Anastrozole drug interactions.

What are the common drug interactions of Restasis and Anastrozole, by gender? *:

female:

Fatigue (feeling of tiredness)
Alopecia (absence of hair from areas of the body)
Dizziness
Headache (pain in head)
Fall
White blood cell count decreased
Drug hypersensitivity
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Anaemia (lack of blood)

male:

Anxiety
Chronic kidney disease
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Weight decreased
Depression
Gout (uric acid crystals building up in the body)

What are the common drug interactions of Restasis and Anastrozole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Discomfort
Hysterectomy
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pain
Psoriasis (immune-mediated disease that affects the skin)
Surgery
Anxiety
Chronic kidney disease
Depression

50-59:

Alopecia (absence of hair from areas of the body)
Anxiety
Emotional distress
Neoplasm malignant (cancer tumour)
Platelet count decreased
Renal impairment (severely reduced kidney function)

60+:

Fatigue (feeling of tiredness)
Fall
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pneumonia
Weight increased
Abdominal distension
Alopecia (absence of hair from areas of the body)
Aphasia (damage to the parts of the brain that control language)
Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
Arthritis (form of joint disorder that involves inflammation of one or more joints)

What are the existing conditions these people have? *

Breast Cancer Female: 8 people, 12.31%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 10.77%
High Blood Cholesterol: 6 people, 9.23%
Pain: 5 people, 7.69%
Osteoporosis (bones weak and more likely to break): 5 people, 7.69%
Urinary Tract Infection: 4 people, 6.15%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 4 people, 6.15%
Ovarian Cancer (cancer of ovary): 4 people, 6.15%
High Blood Pressure: 4 people, 6.15%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.15%

* Approximation only. Some reports may have incomplete information.

Do you take Restasis and Anastrozole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously